Skip to main content

Articles

Page 5 of 10

  1. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Seyedeh Maryam Alavi Naini, Constantin Yanicostas, Rahma Hassan-Abdi, Sébastien Blondeel, Mohamed Bennis, Ryan J. Weiss, Yitzhak Tor, Jeffrey D. Esko and Nadia Soussi-Yanicostas
    Citation: Translational Neurodegeneration 2020 9:45

    The original article was published in Translational Neurodegeneration 2018 7:6

  2. Deficits in synaptic transmission and plasticity are thought to contribute to the pathophysiology of Alzheimer’s disease (AD) and Parkinson’s disease (PD). Several brain stimulation techniques are currently av...

    Authors: Ti-Fei Yuan, Wei-Guang Li, Chencheng Zhang, Hongjiang Wei, Suya Sun, Nan-Jie Xu, Jun Liu and Tian-Le Xu
    Citation: Translational Neurodegeneration 2020 9:44
  3. Parkinson’s disease (PD) is diagnosed when patients exhibit bradykinesia with tremor and/or rigidity, and when these symptoms respond to dopaminergic medications. Yet in the last years there was a greater reco...

    Authors: Elisabeth Dinter, Theodora Saridaki, Leonie Diederichs, Heinz Reichmann and Björn H. Falkenburger
    Citation: Translational Neurodegeneration 2020 9:43
  4. Accumulating reports have suggested that α-synuclein is involved in the pathogenesis of Alzheimer’s disease (AD). As the cerebrospinal fluid (CSF) α-synuclein has been suggested as a potential biomarker of AD,...

    Authors: Jie-Qiong Li, Yan-Lin Bi, Xue-Ning Shen, Hui-Fu Wang, Wei Xu, Chen-Chen Tan, Qiang Dong, Yan-Jiang Wang, Lan Tan and Jin-Tai Yu
    Citation: Translational Neurodegeneration 2020 9:41
  5. Mitochondria are the energy center of cell operations and are involved in physiological functions and maintenance of metabolic balance and homeostasis in the body. Alterations of mitochondrial function are ass...

    Authors: Chunhui Huang, Sen Yan and Zaijun Zhang
    Citation: Translational Neurodegeneration 2020 9:40
  6. Parkinson’s disease (PD) is characterized by motor deficits and a wide variety of non-motor symptoms. The age of onset, rate of disease progression and the precise profile of motor and non-motor symptoms displ...

    Authors: Christian U. von Linstow, Ziv Gan-Or and Patrik Brundin
    Citation: Translational Neurodegeneration 2020 9:39
  7. Misfolded oligomeric α-synuclein plays a pivotal role in the pathogenesis of α-synucleinopathies including Parkinson’s disease and multiple system atrophy, and its detection parallels activation of microglia a...

    Authors: Miguel Lemos, Serena Venezia, Violetta Refolo, Antonio Heras-Garvin, Sabine Schmidhuber, Armin Giese, Andrei Leonov, Sergey Ryazanov, Christian Griesinger, Gergana Galabova, Guenther Staffler, Gregor Karl Wenning and Nadia Stefanova
    Citation: Translational Neurodegeneration 2020 9:38
  8. Alzheimer’s disease (AD) immunotherapy with antibodies targeting amyloid-β (Aβ) has been extensively explored in clinical trials. The aim of this study was to study the long-term brain distribution of two radi...

    Authors: Tobias Gustavsson, Stina Syvänen, Paul O’Callaghan and Dag Sehlin
    Citation: Translational Neurodegeneration 2020 9:37
  9. There is an urgent need to understand the pathways and processes underlying Alzheimer’s disease (AD) for early diagnosis and development of effective treatments. This study was aimed to investigate Alzheimer’s...

    Authors: Jin Xu, Giulia Bankov, Min Kim, Asger Wretlind, Jodie Lord, Rebecca Green, Angela Hodges, Abdul Hye, Dag Aarsland, Latha Velayudhan, Richard J. B. Dobson, Petroula Proitsi and Cristina Legido-Quigley
    Citation: Translational Neurodegeneration 2020 9:36
  10. Circular RNAs (circRNAs) are a type of covalently closed, single-stranded circular noncoding RNA that can affect the expression of many protein-coding genes. Growing evidence has shown that circRNAs play criti...

    Authors: Yuan Zhang, Yanfang Zhao, Ying Liu, Man Wang, Wanpeng Yu and Lei Zhang
    Citation: Translational Neurodegeneration 2020 9:35
  11. In recent years, many studies have investigated the correlations between Parkinson’s disease (PD) and vitamin D status, but the conclusion remains elusive. The present review focuses on the associations betwee...

    Authors: Lingling Lv, Xuling Tan, Xinke Peng, Rongrong Bai, Qile Xiao, Ting Zou, Jieqiong Tan, Hainan Zhang and Chunyu Wang
    Citation: Translational Neurodegeneration 2020 9:34
  12. Common and rare variants of guanosine triphosphate cyclohydrolase 1 (GCH1) gene may play important roles in Parkinson’s disease (PD). However, there is a lack of comprehensive analysis of GCH1 genotypes, especial...

    Authors: Hong-xu Pan, Yu-wen Zhao, Jun-pu Mei, Zheng-huan Fang, Yige Wang, Xun Zhou, Yang-jie Zhou, Rui Zhang, Kai-lin Zhang, Li Jiang, Qian Zeng, Yan He, Zheng Wang, Zhen-hua Liu, Qian Xu, Qi-ying Sun…
    Citation: Translational Neurodegeneration 2020 9:31
  13. Diseases and disorders with a chronic neuroinflammatory component are often linked with changes in brain metabolism. Among neurodegenerative disorders, people living with human immunodeficiency virus (HIV) and...

    Authors: Kalimuthusamy Natarajaseenivasan, Santhanam Shanmughapriya, Prema Velusamy, Matthew Sayre, Alvaro Garcia, Nestor Mas Gomez and Dianne Langford
    Citation: Translational Neurodegeneration 2020 9:32
  14. Progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) dementia can be predicted by clinical features and a combination of biomarkers may increase the predictive power. In the present study...

    Authors: Aonan Zhao, Yuanyuan Li, Yi Yan, Yinghui Qiu, Binyin Li, Wei Xu, Ying Wang, Jun Liu and Yulei Deng
    Citation: Translational Neurodegeneration 2020 9:30
  15. Early morning off (EMO) is a common feature of Parkinson’s disease (PD). This study aimed to characterize its clinical features and develop a convenient and pragmatic self-assessment instrument in a Chinese na...

    Authors: Chao Han, Wei Mao, Jing An, Lifei Jiao and Piu Chan
    Citation: Translational Neurodegeneration 2020 9:29
  16. Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disease affecting about 2–3% of population above the age of 65. In recent years, Parkinson’s research has mainly focused on motor and non-mo...

    Authors: Ning-Ning Che and Hong-Qi Yang
    Citation: Translational Neurodegeneration 2020 9:28
  17. MicroRNAs (miRNAs) are endogenous non-coding RNAs that regulate gene expression at the post-transcriptional level and are key modulators in neurodegenerative diseases. Overexpressed miRNAs play an important ro...

    Authors: Ki Yoon Kim, Yu Ri Kim, Kyung Won Choi, Mijung Lee, Somyung Lee, Wooseok Im, Je-Young Shin, Jin Young Kim, Yoon Ho Hong, Manho Kim, Jong-Il Kim and Jung-Joon Sung
    Citation: Translational Neurodegeneration 2020 9:23
  18. The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. H...

    Authors: Julia Remnestål, Linn Öijerstedt, Abbe Ullgren, Jennie Olofsson, Sofia Bergström, Kim Kultima, Martin Ingelsson, Lena Kilander, Mathias Uhlén, Anna Månberg, Caroline Graff and Peter Nilsson
    Citation: Translational Neurodegeneration 2020 9:27
  19. In Alzheimer’s Disease (AD), about one-third of the risk genes identified by GWAS encode proteins that function predominantly in the endocytic pathways. Among them, the Ras and Rab Interactor 3(RIN3) is a guan...

    Authors: Ruinan Shen, Xiaobei Zhao, Lu He, Yongbo Ding, Wei Xu, Suzhen Lin, Savannah Fang, Wanlin Yang, Kijung Sung, Brian Spencer, Robert A. Rissman, Ming Lei, Jianqing Ding and Chengbiao Wu
    Citation: Translational Neurodegeneration 2020 9:26
  20. An amendment to this paper has been published and can be accessed via the original article.

    Authors: William R. Swindell, Krzysztof Bojanowski, Mark S. Kindy, Raymond M. W. Chau and Dorothy Ko
    Citation: Translational Neurodegeneration 2020 9:24

    The original article was published in Translational Neurodegeneration 2018 7:30

  21. Alzheimer’s and Parkinson’s diseases are the most prevalent neurodegenerative disorders. Their etiologies are idiopathic, and treatments are symptomatic and orientated towards cognitive or motor deficits. Neur...

    Authors: Isabel Ubeda-Bañon, Daniel Saiz-Sanchez, Alicia Flores-Cuadrado, Ernesto Rioja-Corroto, Melania Gonzalez-Rodriguez, Sandra Villar-Conde, Veronica Astillero-Lopez, Juan Pablo Cabello-de la Rosa, Maria Jose Gallardo-Alcañiz, Julia Vaamonde-Gamo, Fernanda Relea-Calatayud, Lucia Gonzalez-Lopez, Alicia Mohedano-Moriano, Alberto Rabano and Alino Martinez-Marcos
    Citation: Translational Neurodegeneration 2020 9:22
  22. Mitochondrial dysfunction plays a central role in the formation of neuroinflammation and oxidative stress, which are important factors contributing to the development of brain disease. Ample evidence suggests ...

    Authors: Luodan Yang, Hannah Youngblood, Chongyun Wu and Quanguang Zhang
    Citation: Translational Neurodegeneration 2020 9:19
  23. Subjective cognitive decline (SCD) is a preclinical stage along the Alzheimer’s disease (AD) continuum. However, little is known about the aberrant patterns of connectivity and topological alterations of the b...

    Authors: Haifeng Chen, Xiaoning Sheng, Caimei Luo, Ruomeng Qin, Qing Ye, Hui Zhao, Yun Xu and Feng Bai
    Citation: Translational Neurodegeneration 2020 9:21
  24. Alzheimer’s disease is a neurodegenerative disorder. Therapeutically, a transplantation of bone marrow mesenchymal stem cells (BMMSCs) can play a beneficial role in animal models of Alzheimer’s disease. Howeve...

    Authors: Chuan Qin, Yalan Lu, Kewei Wang, Lin Bai, Guiying Shi, Yiying Huang and Yongning Li
    Citation: Translational Neurodegeneration 2020 9:20
  25. Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy, and irritability occur in prodromal phases of clinical Alzheimer’s disease (AD), which might be an increased risk for later developing AD. H...

    Authors: Peng-Hui Ai, Si Chen, Xian-Dong Liu, Xiao-Na Zhu, Yuan-Bo Pan, Dong-Fu Feng, Shengdi Chen, Nan-Jie Xu and Suya Sun
    Citation: Translational Neurodegeneration 2020 9:18
  26. Alzheimer’s disease (AD) is the most common type of dementia, and no disease-modifying treatments are available to halt or slow its progression. Amyloid-beta (Aβ) is suggested to play a pivotal role in the pat...

    Authors: Yuan Cheng, Ding-Yuan Tian and Yan-Jiang Wang
    Citation: Translational Neurodegeneration 2020 9:16
  27. Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson’s disease (PD). In this study, we aim to identify CSF ...

    Authors: Nour K. Majbour, Jan O. Aasly, Eldbjørg Hustad, Mercy A. Thomas, Nishant N. Vaikath, Naser Elkum, Wilma D. J. van de Berg, Takahiko Tokuda, Brit Mollenhauer, Henk W. Berendse and Omar M. A. El-Agnaf
    Citation: Translational Neurodegeneration 2020 9:15
  28. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Heinz Reichmann, Andrew Lees, José-Francisco Rocha, Diogo Magalhães and Patrício Soares-da-Silva
    Citation: Translational Neurodegeneration 2020 9:14

    The original article was published in Translational Neurodegeneration 2020 9:9

  29. Parkinson’s disease (PD) is one of the neurodegeneration diseases characterized by the gradual loss of dopaminergic (DA) neurons in the substantia nigra region of the brain. Substantial evidence indicates that...

    Authors: Xiao-Yu Cheng, Sangita Biswas, Juan Li, Cheng-Jie Mao, Olga Chechneva, Jing Chen, Kai Li, Jiao Li, Jin-Ru Zhang, Chun-Feng Liu and Wen-Bin Deng
    Citation: Translational Neurodegeneration 2020 9:13
  30. The identification of circulating biomarkers that closely correlate with Parkinson’s Disease (PD) has failed several times in the past. Nevertheless, in this pilot study, a translational approach was conducted...

    Authors: Sandra I. Anjo, Patrícia Valério dos Santos, Luiza Rosado, Graça Baltazar, Inês Baldeiras, Diana Pires, Andreia Gomes, Cristina Januário, Miguel Castelo-Branco, Mário Grãos and Bruno Manadas
    Citation: Translational Neurodegeneration 2020 9:11
  31. The homeostasis of metal ions, such as iron, copper, zinc and calcium, in the brain is crucial for maintaining normal physiological functions. Studies have shown that imbalance of these metal ions in the brain...

    Authors: Lu Wang, Ya-Ling Yin, Xin-Zi Liu, Peng Shen, Yan-Ge Zheng, Xin-Rui Lan, Cheng-Biao Lu and Jian-Zhi Wang
    Citation: Translational Neurodegeneration 2020 9:10
  32. The efficacy and safety of opicapone, a once-daily catechol-O-methyltransferase inhibitor, have been established in two large randomized, placebo-controlled, multinational pivotal trials. Still, clinical evide...

    Authors: Heinz Reichmann, Andrew Lees, José-Francisco Rocha, Diogo Magalhães and Patrício Soares-da-Silva
    Citation: Translational Neurodegeneration 2020 9:9

    The Correction to this article has been published in Translational Neurodegeneration 2020 9:14

  33. Older African Americans are more likely to develop Alzheimer’s disease (AD) than older Caucasians, and this difference cannot be readily explained by cerebrovascular and socioeconomic factors alone. We previou...

    Authors: Maria B. Misiura, J. Christina Howell, Junjie Wu, Deqiang Qiu, Monica W. Parker, Jessica A. Turner and William T. Hu
    Citation: Translational Neurodegeneration 2020 9:8
  34. Multiple system atrophy (MSA) is a debilitating and fatal neurodegenerative disorder. The disease severity warrants urgent development of disease-modifying therapy, but the disease pathogenesis is still enigma...

    Authors: Seiji Kaji, Takakuni Maki, Tomoyuki Ishimoto, Hodaka Yamakado and Ryosuke Takahashi
    Citation: Translational Neurodegeneration 2020 9:7
  35. The direct reprogramming of somatic cells into induced neural progenitor cells (iNPCs) has been envisioned as a promising approach to overcome ethical and clinical issues of pluripotent stem cell transplantati...

    Authors: Xiaohuan Xia, Chunhong Li, Yi Wang, Xiaobei Deng, Yizhao Ma, Lu Ding and Jialin Zheng
    Citation: Translational Neurodegeneration 2020 9:6
  36. α-Synuclein is a small soluble protein, whose physiological function in the healthy brain is poorly understood. Intracellular inclusions of α-synuclein, referred to as Lewy bodies (LBs), are pathological hallm...

    Authors: Niccolo Candelise, Matthias Schmitz, Katrin Thüne, Maria Cramm, Alberto Rabano, Saima Zafar, Erik Stoops, Hugo Vanderstichele, Anna Villar-Pique, Franc Llorens and Inga Zerr
    Citation: Translational Neurodegeneration 2020 9:5
  37. Tourette syndrome (TS) is a childhood-onset neuropsychiatric disorder characterized by the presence of multiple motor and vocal tics. TS usually co-occurs with one or multiple psychiatric disorders. Although b...

    Authors: Wenying Xu, Chencheng Zhang, Wissam Deeb, Bhavana Patel, Yiwen Wu, Valerie Voon, Michael S. Okun and Bomin Sun
    Citation: Translational Neurodegeneration 2020 9:4
  38. In the original publication of this article [1], the following statement should be added in the Acknowledgement section.

    Authors: Jeroen Van Schependom, Kaat Guldolf, Marie Béatrice D’hooghe, Guy Nagels and Miguel D’haeseleer
    Citation: Translational Neurodegeneration 2020 9:3

    The original article was published in Translational Neurodegeneration 2019 8:37

  39. Parkinson’s disease is characterized by dopaminergic neuron loss and intracellular inclusions composed mainly of alpha synuclein (α-syn), but the mechanism of pathogenesis is still obscure. In recent years, mo...

    Authors: Caroline Haikal, Qian-Qian Chen and Jia-Yi Li
    Citation: Translational Neurodegeneration 2019 8:38
  40. Multiple sclerosis (MS) is a complex chronic inflammatory and degenerative disorder of the central nervous system. Accelerated brain volume loss, or also termed atrophy, is currently emerging as a popular imag...

    Authors: Jeroen Van Schependom, Kaat Guldolf, Marie Béatrice D’hooghe, Guy Nagels and Miguel D’haeseleer
    Citation: Translational Neurodegeneration 2019 8:37

    The Correction to this article has been published in Translational Neurodegeneration 2020 9:3

  41. We recently demonstrated an endolysosomal accumulation of the β-secretase-derived APP C-terminal fragment (CTF) C99 in brains of Alzheimer disease (AD) mouse models. Moreover, we showed that the treatment with...

    Authors: Inger Lauritzen, Anaïs Bécot, Alexandre Bourgeois, Raphaëlle Pardossi-Piquard, Maria-Grazia Biferi, Martine Barkats and Fréderic Checler
    Citation: Translational Neurodegeneration 2019 8:35
  42. CSF1R-related leukoencephalopathy, also known as hereditary diffuse leukoencephalopathy with spheroids (HDLS), is a rare white-matter encephalopathy characterized by motor and neuropsychiatric symptoms due to col...

    Authors: Wo-Tu Tian, Fei-Xia Zhan, Qing Liu, Xing-Hua Luan, Chao Zhang, Liang Shang, Ben-Yan Zhang, Si-Jian Pan, Fei Miao, Jiong Hu, Ping Zhong, Shi-Hua Liu, Ze-Yu Zhu, Hai-Yan Zhou, Suya Sun, Xiao-Li Liu…
    Citation: Translational Neurodegeneration 2019 8:32
  43. Different oscillations of brain networks could carry different dimensions of brain integration. We aimed to investigate oscillation-specific nodal alterations in patients with Parkinson’s disease (PD) across e...

    Authors: Xiaojun Guan, Tao Guo, Qiaoling Zeng, Jiaqiu Wang, Cheng Zhou, Chunlei Liu, Hongjiang Wei, Yuyao Zhang, Min Xuan, Quanquan Gu, Xiaojun Xu, Peiyu Huang, Jiali Pu, Baorong Zhang and Min-Ming Zhang
    Citation: Translational Neurodegeneration 2019 8:36

Affiliated with

Annual Journal Metrics

  • 2023 Citation Impact
    10.8 - 2-year Impact Factor
    11.6 - 5-year Impact Factor
    2.374 - SNIP (Source Normalized Impact per Paper)
    3.371 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage
    767,289 downloads
    3,389 Altmetric mentions